欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号ES/V/0430/001
药品名称Buprelab 0,3 mg/ml solution for injection for dogs and cats
活性成分
    • BUPRENORPHINE hydrochloride 0.3 mg/ml
剂型Solution for injection
上市许可持有人Labiana Life Sciences S.A. Calle Venus 26 Poligono Industrial Can Parellada 08228 Terrassa (Barcelona) Spain
参考成员国 - 产品名称Spain (ES)
Buprelab 0,3 mg/ml solución inyectable para perros y gatos
互认成员国 - 产品名称
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Romania (RO)
    • Germany (DE)
    • Denmark (DK)
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
      Buprelab 0,3 mg/ml
    • Luxembourg (LU)
    • France (FR)
    • Sweden (SE)
    • Finland (FI)
许可日期2023/10/18
最近更新日期2025/03/07
药物ATC编码
    • QN02AE01 buprenorphine
申请类型
  • TypeLevel1：non-food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase